Subscribe To

Price Alert Latest News Economic Calendar News

TLRY / 7 Growth Stocks for Gangbuster Returns by 2030

There has been a flurry of economic news, both good and bad, which has rattled most investors. Indeed, for many, it may seem impossible to dissect this ever-changing news flow while actively managing a portfolio based on any potential implications. Read More

Demo Live Account See Partner Details

Content Topics

Growth

Stocks

Gangbuster

Returns

2030

Stock

TLRY

Posted: Nov 7 2022, 17:54

Author Name: InvestorPlace

TLRY News

By InvestorPlace
October 25, 2023

Why Undervalued Tilray Stock Is a Hidden Cannabis Gem in Plain Sight

Here's a buy-low-and-just-hold-it opportunity that will reward patient individuals. Tilray (NASDAQ: TLRY ) stock is trading at a low price in October,

By InvestorPlace
October 22, 2023

Tilray Stock's Tumble: A Buying Opportunity or a Cautionary Tale?

Tilray Brands (NASDAQ: TLRY ) presents an intriguing opportunity, especially when looking at TLRY stock in the cannabis sector. Tilray has established

By Invezz
October 12, 2023

Tilray stock price forecast: TLRY could crash by ~25% soon

Tilray (NASDAQ: TLRY) stock price has erased most of the gains it made in September as hopes of regulatory clarity rose. After surging to $3.40 on Sep

By Seeking Alpha
October 11, 2023

Tilray Shorts Surge On More Dilution

Tilray's short interest has reached a new 52-week high, indicating growing skepticism and concerns over the company's financial situation. The number

By The Motley Fool
October 7, 2023

3 Key Metrics to Watch for Tilray Stock

Tilray's marijuana business is still unprofitable. Its alcohol segment is a rising star.

By The Motley Fool
October 6, 2023

Better Turnaround Stock: Tilray Brands vs. SNDL

Tilray Brands has been hampered in realizing its multinational marijuana ambitions. SNDL is gaining strength in Canada, but the competition might be a

By Zacks Investment Research
October 5, 2023

Tilray Brands (TLRY) Q1 Loss Wider, Revenues Increase Y/Y

Tilray Brands (TLRY) posts wider-than-expected loss per share in first-quarter fiscal 2024.

By The Motley Fool
October 5, 2023

Tilray's Cannabis Business Leads the Way (for Now) as Losses Narrow

Tilray announced record quarterly revenue led by cannabis segment sales. Profits technically fell short of expectations, hurt by acquisition costs and

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.